Saira Ramasastry - 02 Jun 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
02 Jun 2025
Net transactions value
-$342,543
Form type
4
Filing time
04 Jun 2025, 16:11:47 UTC
Previous filing
02 Jun 2025
Next filing
10 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ramasastry Saira Director C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY /s/ Judit Ryvkin, Attorney-in-Fact 04 Jun 2025 0001547959

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale $263,492 -5,703 -100% $46.20 0 02 Jun 2025 Direct
transaction MIRM Common Stock Options Exercise $35,300 +2,500 $14.12 2,500 03 Jun 2025 Direct
transaction MIRM Common Stock Sale $114,352 -2,500 -100% $45.74 0 03 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Options Exercise $0 -2,500 -100% $0.000000 0 03 Jun 2025 Common Stock 2,500 $14.12 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.